Your email has been sent.
Centre Pointe - Buildings A, B & C/D 1865-1895 W 2100 S 230,180 SF 100% Leased Flex Building Salt Lake City, UT 84119 For Sale
Investment Highlights
- Stable Cash Flow with Sticky Tenancy
- Differentiated Office/R&D Asset with Exceptional Accessibility
- Opportunity to Acquire Below Replacement Cost
Executive Summary
Centre Pointe recently became fully leased, providing new ownership with stable in-place income and built-in contractual lease escalations. The tenant roster includes a diverse mix of local and multinational companies operating across electronics, biopharmaceuticals, artificial intelligence, advanced materials, and immunotherapy.
Centre Pointe is well-positioned to serve the Salt Lake Valley’s growing base of advanced manufacturing, life science, and technology users. Its combination of modern, highly functional improvements, diversified tenancy, attractive in-place cash flow, and direct access to State Route 201, I-15, I-215, and I-80 creates a compelling opportunity to acquire a differentiated flex and laboratory asset within one of the region’s most connected employment corridors.
Property Facts
Major Tenants Click Here to Access
- Tenant
- Industry
- SF Occupied
- Rent/SF
- Lease Type
- Lease End
-
- Professional, Scientific, and Technical Services
- -
-
$9.99
-
Lorem Ipsum
-
Jan 0000
Echelon Biosciences, Inc. is a biotechnology and life sciences company focused on the development and supply of specialized research reagents, assays, and services related to lipid biology and cell signaling. Founded in 1997 as Echelon Research Laboratories by two University of Utah professors, the company was established to advance the science of lipid signaling and enable new diagnostic and therapeutic approaches for complex diseases. Echelon’s offerings include synthetic lipids, peptides, biochemical reagents, antibodies, bioassays, and lipid nanoparticle (LNP) formulation services used in academic, pharmaceutical, and biotechnology research. The company operates primarily from Salt Lake City, where it supports research, manufacturing, quality control, and administrative functions. Echelon has developed a strong reputation as a supplier of ionizable and specialty lipids used in drug delivery systems, including those relevant to mRNA-based therapeutics. In August 2024, Echelon Biosciences was acquired by Vion Biosciences and now operates as a subsidiary, continuing to serve its existing customer base while expanding its capabilities within a broader biopharmaceutical platform.
| Tenant | Industry | SF Occupied | Rent/SF | Lease Type | Lease End | |
|
|
Professional, Scientific, and Technical Services | - | $9.99 | Lorem Ipsum | Jan 0000 |
Property Taxes
| Parcel Number | 15-22-101-010-0000 | Improvements Assessment | $15,406,500 |
| Land Assessment | $1,989,700 | Total Assessment | $17,396,200 |
Property Taxes
